Jamjoom Pharmaceuticals Factory Company

4015

SA15QGU1UNH6

Pharmaceuticals

Market Closed - Saudi Arabian S.E. Other stock markets 13:20:04 28/05/2024 BST			5-day change	1st Jan Change
132.6 ^SAR	0.00%		-2.21%	+15.30%

05-09	Tadawul Shares Plunge Thursday as Saudi Arabia’s March Industrial Output Falls	MT
05-09	Jamjoom Pharmaceuticals Posts Higher Q1 Net Profit, Revenue	MT

Jamjoom Pharmaceuticals Factory Company has filed an IPO.

December 28, 2022 at 05:00 am

Jamjoom Pharmaceuticals Factory Company has filed an IPO.

Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 2,100,000

Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 18,900,000

Transaction Features: Regulation S

Latest news about Jamjoom Pharmaceuticals Factory Company

Tadawul Shares Plunge Thursday as Saudi Arabia’s March Industrial Output Falls	05-09	MT
Jamjoom Pharmaceuticals Posts Higher Q1 Net Profit, Revenue	05-09	MT
Jamjoom Pharmaceuticals Factory Declares Second Interim Dividend for FY23	04-04	MT
Jamjoom Pharmaceuticals Factory Posts Higher FY23 Profit, Revenue	03-25	MT
Jamjoom Pharmaceuticals Factory Company Announces Contract Sign Off with Local Content & Government Procurement Authority	02-01	CI
Jamjoom Pharmaceuticals Factory Company(SASE:4015) added to S&P Pan Arab Composite	12-18	CI
Jamjoom Pharmaceuticals Factory Company(SASE:4015) added to S&P Global BMI Index	12-18	CI
Saudi Arabia healthcare group Fakeeh Care weighs IPO, appoints HSBC - sources	27/08/23	RE
Jamjoom Pharmaceuticals Factory Company has completed an IPO in the amount of SAR 1.26 billion.	06/06/23	CI
Jamjoom Pharmaceuticals Factory Company has filed an IPO.	28/12/22	CI

Chart Jamjoom Pharmaceuticals Factory Company

Duration

Period

Chart Jamjoom Pharmaceuticals Factory Company

More charts

Company Profile

Jamjoom Pharmaceuticals Factory Company SJSC is a Saudi Arabia-based Company, which produces human medicines, nutraceuticals, antibiotics, general analgesics, medicines for treatment of cough, allergy, asthma, heart diseases, blood pressure, diarrhea, vomiting, ulcer and acidity, treatment of various skin infections, cancer diseases, eye drops and ointments and cosmeceuticals. The Company operates two segments, which include pharmaceutical products, that represents medicines or drugs, which all are essential for the prevention and treatment of diseases, and protection of public health; and Consumer health products segment that represents the products sold directly to consumers. The Companyâs subsidiaries include Al Jamjoom Pharma for Pharmaceutical Industries and Jamjoom Pharmaceutical Industry and Commerce Company Limited and the Company also operates approximately 8 branches.

Sector

Pharmaceuticals

Calendar

04/06/2024 - Extraordinary Shareholders Meeting

More about the company

Income Statement Evolution

More financial data

Ratings for Jamjoom Pharmaceuticals Factory Company

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

132.6 SAR

Average target price

146.6 SAR

Spread / Average Target

+10.57%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
JAMJOOM PHARMACEUTICALS FACTORY COMPANY	+15.30%	2.48B
SUN PHARMACEUTICAL INDUSTRIES LTD.	+17.03%	42.25B
OTSUKA HOLDINGS CO., LTD.	+15.24%	21.27B
SANDOZ GROUP AG	+19.33%	15.23B
CIPLA LIMITED	+19.06%	14.36B
ZYDUS LIFESCIENCES LIMITED	+50.46%	12.74B
THE MEDICINES COMPANY	-0.05%	6.79B
ONO PHARMACEUTICAL CO., LTD.	-12.16%	6.61B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+14.28%	5.66B

Generic Pharmaceuticals